Devroe Eric
Chief Operating Officer
Devroe Eric has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Devroe Eric is listed as Chief Operating Officer at Acrivon Therapeutics, Inc. Inside the rolling window, Devroe Eric reported 1 open-market purchase totaling $17K in ACRV and 1 open-market sale totaling $1K in ACRV. The largest disclosed transaction in the window is a purchase of 10,000 ACRV shares on Jan 13, 2026, worth $17K.
Companies traded
Other insiders at ACRV
Insider Buying
$17K
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Devroe Eric made?
Devroe Eric has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Devroe Eric trade?
Devroe Eric has filed SEC Form 4 disclosures for 1 company, including ACRV.
When was Devroe Eric's most recent SEC Form 4 filing?
Devroe Eric's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Devroe Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Devroe Eric is listed as Chief Operating Officer.
What is Devroe Eric's total buy and sell value in the current window?
Inside the rolling retention window, Devroe Eric bought $17K and sold $1K based on SEC Form 4 filings.
What was Devroe Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 ACRV shares on 2026-01-13, worth $17K, per SEC Form 4 filings.